Genesis Healthcare Statistics
Total Valuation
GENN has a market cap or net worth of 24,705.
| Market Cap | 24,705 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
GENN has 123.52 million shares outstanding.
| Current Share Class | 122.78M |
| Shares Outstanding | 123.52M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.00% |
| Float | 122.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 0.00 |
| P/OCF Ratio | 0.00 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23
| Current Ratio | 0.23 |
| Quick Ratio | 0.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | 15.15 |
| Debt / FCF | 72.16 |
| Interest Coverage | -1.99 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3.87% |
| Return on Invested Capital (ROIC) | -5.58% |
| Return on Capital Employed (ROCE) | -124.02% |
| Revenue Per Employee | 88,778 |
| Profits Per Employee | -1,340 |
| Employee Count | 44,000 |
| Asset Turnover | 0.90 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.61M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.82% in the last 52 weeks. The beta is -1.05, so GENN's price volatility has been lower than the market average.
| Beta (5Y) | -1.05 |
| 52-Week Price Change | -81.82% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 43.33 |
| Average Volume (20 Days) | 11,222 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.76 |
Income Statement
In the last 12 months, GENN had revenue of 3.91 billion and -58.96 million in losses. Loss per share was -0.53.
| Revenue | 3.91B |
| Gross Profit | 1.65B |
| Operating Income | -269.78M |
| Pretax Income | -106.98M |
| Net Income | -58.96M |
| EBITDA | -161.94M |
| EBIT | -269.78M |
| Loss Per Share | -0.53 |
Balance Sheet
The company has 212.07 million in cash and 3.81 billion in debt, giving a net cash position of -3.60 billion or -29.13 per share.
| Cash & Cash Equivalents | 212.07M |
| Total Debt | 3.81B |
| Net Cash | -3.60B |
| Net Cash Per Share | -29.13 |
| Equity (Book Value) | -1.16B |
| Book Value Per Share | -7.35 |
| Working Capital | -2.98B |
Cash Flow
In the last 12 months, operating cash flow was 315.73 million and capital expenditures -262.93 million, giving a free cash flow of 52.80 million.
| Operating Cash Flow | 315.73M |
| Capital Expenditures | -262.93M |
| Free Cash Flow | 52.80M |
| FCF Per Share | 0.43 |
Margins
Gross margin is 42.24%, with operating and profit margins of -6.91% and -1.51%.
| Gross Margin | 42.24% |
| Operating Margin | -6.91% |
| Pretax Margin | -2.74% |
| Profit Margin | -1.51% |
| EBITDA Margin | -4.15% |
| EBIT Margin | -6.91% |
| FCF Margin | 1.35% |
Dividends & Yields
GENN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 32.34% |
| Shareholder Yield | n/a |
| Earnings Yield | -238,668.29% |
| FCF Yield | 213,730.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GENN has an Altman Z-Score of -0.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.49 |
| Piotroski F-Score | 3 |